Analyst forecasts go beyond mere numbers; they offer a strategic lens into future market potential. For investors on the lookout for the next breakout opportunity, certain Nifty500 stocks stand out as compelling picks. Consensus estimates from Trendlyne indicate that many Nifty500 stocks have the potential to deliver significant returns over the coming 12 months.These upside projections, reflecting average expected price gains, offer a data-backed benchmark for investors seeking high-potential opportunities within the Nifty500 universe. In this overview, we spotlight seven standout Nifty500 stocks, each backed by ratings from five or more analysts with estimated returns ranging from 25% to as high as 88% over the coming year.
Aluminium prices have surged to record levels in India and abroad, driven by tight domestic supply, robust industrial demand, high energy costs, and geopolitical disruptions. Import restrictions, global trade shifts, tariffs, and structural constraints continue to widen regional price gaps. With EVs and renewables boosting demand, the long-term outlook remains firm despite volatility
HDFC Bank added Rs 9,149.13 crore, taking its market capitalisation to Rs 15,20,524.34 crore, and that of Hindustan Unilever rose by Rs 2,878.25 crore to Rs 5,70,187.06 crore
Seven mutual funds trimmed their holdings in about 20 midcap stocks in October as part of routine portfolio management, according to a report by Nuvama Institutional Equities.
In October, seven unique stocks valued above Rs 100 crore were identified, each held exclusively by a single fund house, highlighting selective conviction among mutual fund managers.
Tech companies are borrowing billions for artificial intelligence. Lenders are now seeking protection against potential defaults. Derivatives trading on companies like Oracle and Meta Platforms has surged. This indicates a shift in capital markets as AI drives massive investment and borrowing. Investors are hedging their exposure to this evolving landscape.
Nifty ended higher after a late rebound driven by financials, pharma, and FMCG, supported by sentiment linked to the NDAs Bihar victory. Technical indicators suggest strength above key support levels. Analysts recommend GRSE and Thyrocare based on strong breakouts, robust volume patterns, and sustained momentum across major moving averages
